Lactulosum

Lactulose, the active ingredient in Lactulosum, is an osmotic laxative presented as a liquid solution for oral use. It is employed to relieve constipation and to manage hepatic encephalopathy in patients with liver disease, helping to reduce blood ammonia levels.

GNH USA supplies Lactulosum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product quality, regulatory compliance, and responsive technical support throughout the supply chain.

Lactulose is used as an osmotic laxative and ammonia‑lowering agent in several clinical situations. - Constipation: softens stools and increases bowel frequency, facilitating easier passage. - Hepatic encephalopathy: lowers intestinal ammonia production, helping to improve mental status in patients with liver disease. - Prevention of hepatic encephalopathy recurrence: maintains low ammonia levels to reduce the risk of future episodes.

Lactulose may cause a range of adverse reactions, most of which are related to its laxative action and colonic fermentation.

Common Side Effects: - Abdominal bloating: feeling of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas production. - Diarrhea: loose, watery stools occurring more frequently. - Abdominal cramps: intermittent painful contractions of the gut.

Serious or Rare Side Effects: - Electrolyte imbalance: disturbances such as low potassium due to excessive fluid loss. - Severe dehydration: marked loss of body water requiring medical attention. - Allergic reaction: rash, itching, or swelling indicating hypersensitivity. - Hypernatremia: elevated blood sodium levels in rare cases.

When prescribing lactulose, clinicians should consider several safety measures to minimize risks and ensure appropriate use. - Renal function assessment: evaluate kidney status, especially in patients with pre‑existing impairment. - Electrolyte monitoring: check serum potassium and sodium during prolonged therapy. - Diabetes caution: monitor blood glucose as lactulose may affect glycemic control. - Pediatric use: adjust dosing carefully and observe for dehydration in children. - Concomitant laxative use: avoid combining with other strong laxatives to prevent excessive fluid loss. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and direct sunlight.

Lactulose can interact with other medicines, influencing its efficacy or increasing the risk of adverse effects.

Major Interactions (Avoid): - Antacids containing magnesium: may enhance the osmotic effect and cause severe diarrhea. - Broad‑spectrum antibiotics: can alter colonic flora, reducing lactulose conversion and effectiveness. - Diuretics: increase risk of electrolyte disturbances when combined with lactulose‑induced fluid loss.

Moderate Interactions (Monitor Closely): - Metformin: both agents may affect gastrointestinal tolerance; monitor for increased GI upset. - Warfarin: occasional reports of altered INR; check coagulation parameters regularly. - Oral hypoglycemics: lactulose may potentiate hypoglycaemia; observe blood glucose levels.